Arvinas shares dived 40% following results from a Phase 3 clinical trial evaluating vepdegestrant as a treatment for a type of metastatic breast cancer. Shares were trading around $10.35. The stock is ...

A one-time investment may do wonders if one lets it grow for years. It can generate a corpus from which one may withdraw a ...

The Phase 1b study is evaluating givastomig, a potential best-in-class, Claudin 18.2 (CLDN18.2) x 4-1BB bispecific antibody, targeting CLDN18.2-expressing tumor cells for the treatment of gastric ...

D-150 is a potential backbone therapy that is designed to provide multi-year sustained delivery of anti-VEGF (aflibercept and ...

Liberty Mutual will refund approximately $4 million to around 138,000 Louisiana policyholders after overcharging them on a state-mandated insurance assessment ...

Neurocrine Biosciences announced the initiation of a Phase 1 clinical study for the compound NBI-1140675, a new VMAT2 inhibitor. This development could influence investor sentiment, though the ...

For the year, revenue increased by 1.6% YoY to $50.2b. Liberty Mutual Holding Company Inc.’s fiscal year 2024 (FY 2024) ...

Legal technology company Trust & Will said Tuesday that it has raised $25 million in a Series C funding round led by Moderne ...

Therapeutics announced that the first patients have been enrolled across multiple sites in the 4FRONT-1 Phase 3 clinical ...

European gas prices tumbled as much as 4.2% before reversing losses. “If the EU is delaying its roadmap on how to phase out Russian gas, it’s possible that the original phase-out deadline of ...

"This is a historic moment for 4DMT as we become a Phase 3 company following our initiation of the 4FRONT-1 clinical trial,” said David Kirn, M.D., Co-founder and Chief Executive Officer of 4DMT.

What is the moon phase today? Today, Feb. 13, 2025, the moon is 15 days old and is in the Full Moon phase of its lunar cycle. It is 99% illuminated. Moon phases reveal the passage of time in the ...